Leukemia Clinical Trials in Dallas

Showing 1161-1180 of 1,246 trials

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

NCT00066599

RATIONALE: Voriconazole may be effective in preventing systemic fungal infections following chemotherapy. PURPOSE: Phase II trial to study the effectiveness of voriconazole in preventing systemic fungal infections in children who have neutropenia after receiving chemotherapy for leukemia, lymphoma, or aplastic anemia or in preparation for bone marrow or stem cell transplantation.

Kidney CancerLeukemiaLymphoma+6 more

National Cancer Institute (NCI)Started Jun 2003

Orange, California, United States • San Diego, California, United States • Bethesda, Maryland, United States +4 more locations

COMPLETEDPhase 2< 1 mile

Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen

NCT00852163

The purpose of this study is to determine whether Clofarabine in combination with Busulfan is effective as a preparative transplant regimen for the treatment of leukemia and myelodysplastic syndromes

LeukemiaMyelodysplastic Syndrome

Baylor Research Institute20 participantsStarted Mar 2007

Dallas, Texas, United States

COMPLETEDPhase 2< 1 mile

A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT00777309

This is a randomized, placebo-controlled, double blind phase 2 study designed to compare treatment with ARQ 197 plus erlotinib to erlotinib plus placebo in patients with non-small cell lung cancer. The study will enroll patients who have had one prior chemotherapy regimen (other than erlotinib) for NSCLC.

Non Small Cell Lung Cancer

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)167 participantsStarted Sep 2008

Burbank, California, United States • Santa Monica, California, United States • Torrington, Connecticut, United States +35 more locations

Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy

Study of Stem Cell Transplant for Leukemia and Myelodysplastic Syndromes Using Clofarabine and Busulfan Regimen

A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Leukemia Trials in Other Cities

Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia

Topotecan in Treating Children With Refractory Leukemia

Iressa Expanded Access Program (EAP)

Assessment of Alcon's Ocular Image Quantification System

Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia

A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy.

Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors

Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation

Study of the Safety and Tolerability of PCI-32765 in Patients With Recurrent B Cell Lymphoma

A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists

S9912 Combination Chemo in Stage III Ovarian Cancer,

Irinotecan in Treating Patients With Solid Tumors or Lymphoma Who Have Abnormal Liver or Kidney Function or Who Have Received Radiation Therapy to the Pelvis

First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Alvocidib in Patients With Previously Treated Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia Arising From Chronic Lymphocytic Leukemia (CLL)

Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer

Other Conditions in Dallas